Our overarching goal is to unleash the full potential of our immune cells.

We’re exploring the crossroads of synthetic biology, immunology, and cancer biology. We engineer cells so that they achieve maximum therapeutic efficacy at the right place and at the right timing. We employ protein engineering, next-gen sequencing, CRISPR screening, and bioinformatics.

Join us on an exciting journey to shape the future of fully programmable immunity!